Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | +8618964387627 |
| E-mail: | customer_service@efebio.com |
| QQ: | 3012643761 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| RAPTA-C | C16H23Cl2N3PRu | 372948-28-2 | Details |
| EO-1606 | C21H17ClFNO | 344457-87-0 | Details |
| Avenacoside B | C57H92O28 | 35920-91-3 | Details |
| (+)-Isoampelopsin F | C28H22O6 | 354553-38-1 | Details |
| MMP-9-IN-7 | C16H15ClN4O2S2 | 333746-76-2 | Details |
| CB1R antagonist 1 | C18H23F3N2O3S | 334668-69-8 | Details |
| Ancriviroc | C28H37BrN4O3 | 370893-06-4 | Details |
| Tyrosine kinase-IN-7 | C16H15N3OS | 345615-74-9 | Details |
| p53-MDM2-IN-1 | C23H20ClN3O3 | 381717-91-5 | Details |
| BMS-394136 | C24H21Cl2FN4O | 343246-73-1 | Details |
| Hi 76-0079 | C11H13ClN2O3 | 374567-94-9 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| lorvotuzumab | 339306-30-8 | Details |
| Ogremorphin | C21H17N3OS | 352563-21-4 | Details |
| Galiximab | 357613-77-5 | Details |
| Cindunistat | C8H17N3O2S | 364067-22-1 | Details |
| WAY-324208 | C23H21N3O3 | 387371-82-6 | Details |
| 4-Methylpentanoic-d11 acid | C6H12O2 | 344298-98-2 | Details |
| BMS-363131 | C28H40N6O5 | 384829-65-6 | Details |
| Malathion-d7 | C10H12D7O6PS2 | 352438-94-9 | Details |
| Tucotuzumab | 339986-90-2 | Details |
| Vapaliximab | 336801-86-6 | Details |
| Penbutolol | C18H29NO2 | 38363-40-5 | Details |
| Antiviral agent | C20H21N3O2S2 | 380458-45-7 | Details |
| sEH inhibitor-7 | C15H21NO2 | 340221-20-7 | Details |
| Sulcardine 2HCl | 343935-48-8 | Details |
| Tomentosin | C15H20O3 | 33649-15-9 | Details |
| Monascorubramine | C23H27NO4 | 3627-51-8 | Details |
| JNK-IN-13 | C13H7ClN4S | 345986-38-1 | Details |
| LDCA | C8H5Cl3FNO | 349106-80-5 | Details |
| Briakinumab | 339308-60-0 | Details |
| (S)-Isopropyl 2-amino-3-hydroxypropanoate hydrochloride | C6H14ClNO3 | 37592-53-3 | Details |
| 5,7-dimethoxy-2-benzofuran-1(3H)-one | C10H10O4 | 3465-69-8 | Details |
| hMAO-B-IN-5 | C24H22O3 | 358343-63-2 | Details |
| IRES-C11 | C13H11Cl2NO4 | 342416-30-2 | Details |
| BAP1-IN-1 | C18H16N2O2 | 353495-21-3 | Details |
| Ciproquazone | C19H18N2O2 | 33453-23-5 | Details |
| VU041 | C19H20F3N3O | 332943-64-3 | Details |
| SARS-CoV-2 3CLpro-IN-16 | C17H14N2OS | 352659-40-6 | Details |
| XR 5944 | C34H34N8O2 | 343247-32-5 | Details |
| GSK3-IN-3 | C24H35N3O4 | 331963-27-0 | Details |
| Bertilimumab | 375348-49-5 | Details |
| Sergliflozin A | C20H24O7 | 360775-96-8 | Details |
| Aminopeptidase-IN-1 | C18H16N2O6 | 374102-08-6 | Details |
| Antimicrobial agent-14 | C9H8ClNO3S2 | 380576-68-1 | Details |
| Vaxfectin | C45 H90 N O8 P . C36 H73 N2 O2 . Br | 370108-99-9 | Details |
| MCPA-d3 (phenyl-d3) | C9H9ClO3 | 352431-14-2 | Details |
| Telatinib mesylate | C21H20ClN5O6S | 332013-26-0 | Details |
| Dovramilast | C24H28N2O6S | 340019-69-4 | Details |
| BMS641 | C27H23ClO2 | 369364-50-1 | Details |
| WAY-322243 | C18H18N2O2S | 332939-32-9 | Details |
| Uk-390957 | 364321-71-1 | Details |
| JAK2-IN-6 | C14H10ClN3OS2 | 353512-04-6 | Details |
| Dehydrorotenone | 3466-09-9 | Details |
| Decamethoxine | C38H74ClN2O4+ | 38146-42-8 | Details |
| PCSK9-IN-10 | C18H23N5O4 | 368434-98-4 | Details |
| MIF-1 TFA | C13H24N4O3.C2HF3O2 | 35240-69-8 | Details |
| 11β-HSD1-IN-8 | C10H8F3NO3 | 386704-15-0 | Details |
| LabMol-319 | C22H16N2O5 | 381188-63-2 | Details |
| Serine Hydrolase inhibitor-21 | C18H12N2O2S | 366448-34-2 | Details |
| MtUng-IN-1 | C14H12N2O6 | 359826-99-6 | Details |
| AS601245.2TFA (345987-15-7 free base) | C20H16N6S.2C2HF3O2 | 345987-16-8 | Details |
| Talizumab | 380610-22-0 | Details |
| WAY-607695 | C13H12FNO2 | 380469-52-3 | Details |
| SW157765 | C19H13N3O3 | 332063-87-3 | Details |
| IBS008738 | C22H22N4O2 | 385425-03-6 | Details |
| Perfluidone | C14H12F3NO4S2 | 37924-13-3 | Details |
| AZD8309 | C15H14F2N4O2S2 | 333742-48-6 | Details |
| CBS-1114 HCl | C13H13N3.ClH | 33244-00-7 | Details |
| NSC668394 | C17H12Br2N2O3 | 382605-72-3 | Details |
| MBC-11 | C11H20N3O14P3 | 332863-86-2 | Details |
| PK095 | C20H18N4O2S | 380314-37-4 | Details |
| NSC 55655 | C10H6N2O4S | 36140-65-5 | Details |
| AZD 7009 | C23H34N4O5 | 335619-18-6 | Details |
| LY487379 | C21H19F3N2O4S | 353231-17-1 | Details |
| SM4 | C19H16O3 | 365542-77-4 | Details |
| SRPIN-803 | C14H9F3N4O3S | 380572-02-1 | Details |
| Promegestone | C22H30O2 | 34184-77-5 | Details |
| Rovelizumab | 339086-79-2 | Details |
| 4'-Chlorosalicylanilide | C13H10ClNO2 | 3679-63-8 | Details |
| Tadocizumab | 339086-80-5 | Details |
| Phosmet oxon | C11H12NO5PS | 3735-33-9 | Details |
| JY-2 | C13H7Cl2N3O | 339103-05-8 | Details |
| STOCK2S-26016 | C20H19N3O2 | 332922-63-1 | Details |
| Azido-PEG6-MS | C13H27N3O8S | 352439-38-4 | Details |
| Lumiliximab | 357613-86-6 | Details |
| GSK3-IN-2 | C17H19N3OS | 380450-97-5 | Details |
| AR antagonist 3 | C15H18N2O3S | 349573-58-6 | Details |
| 2’-beta-C-Methyl inosine | C11H14N4O5 | 374750-32-0 | Details |
| Sontuzumab | 372075-37-1 | Details |
| Sarizotan | C22H21FN2O | 351862-32-3 | Details |
| Hepcidin antagonist-1 | C16H13Cl2N5 | 338965-09-6 | Details |
| HBV-IN-37 | C23H22ClN3O2S | 380483-01-2 | Details |
| Antibacterial agent 117 | C9H9ClN4S | 341944-06-7 | Details |
| LQZ-7F | C14H7N9O3 | 354543-09-2 | Details |
| WAY-604663 | C20H15N3O2S | 380347-87-5 | Details |
| 3-phenylpropionic acid-d5 | C9H5D5O2 | 35845-62-6 | Details |
| Dimethandrolone Undecanoate | C31H50O3 | 366472-45-9 | Details |
| RO3244794 | C25H19F2NO5 | 361457-01-4 | Details |
| Tolamolol | C19H24N2O4 | 38103-61-6 | Details |
| Product Total： Product Page： | ||||
| 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||